[Corpora-List] [CFP] workshop on Computational Methods in Pharmacovigilance

[Natalia GRABAR]

MIE 2012 workshop

http://natalia.grabar.perso.sfr.fr/CMPV/

Computational Methods in Pharmacovigilance

Pharmacovigilance is the activity related to the collection, analysis and
prevention of adverse drug reactions induced by drugs or biologics. This
activity plays the fundamental role in monitoring the patient safety
during their healthcare process and beyond it. Although this activity
relies on a strong surveillance tradition within the
pharmacoepidemiological area, some limitations appear and generate
uncomfortable cases widely covered by media (such as those related to
Mediator, VIOXX etc). First of all, these are due to the ever increasing
amount of the data to collect and to process, and also to the recording
and storage of these data in the digital form. Hence, the computational
methods may provide with useful and intelligent solutions for a more rapid
and systematic management of these data.

In this workshop, we favour the submission of various and novel
experiments related to the computational methods in pharmacovigilance and
describing different aspects of the pharmacovigilance process, as
performed by acamedic researchers, institutional or industrial people:
– Collection of the pharmacovigilance data: traditionnally, the
pharmacovigilance cases are narrative documents spontaneously submitted by
medical staff, by pharmacists and sometimes even by patients themselves.
The actual concern is that the collection of these cases is far from being
complete. In this situation, special efforts are oriented on the
computational assistance when collecting and gathering the
pharmacovigilance cases from the raw textual sources. Moreover, the
reporting standards and frames are also addressed by the researchers.
– Analysis of the pharmacovigilance data: this step relies on the encoding
of the cases with the dedicated terminologies and then on the semantic and
statistical analysis of these cases. The concerns are related to various
aspects, such as (1) the semantic correspondence between the cases and the
terms; (2) the methods for the encoding of the cases; (3) the managing of
semantic ambiguity and relatedness between the terms; (4) exploitation of
the SMQs and of the related data; (5) terminological and ontological
representation within the dedicated terminologies; (6) computational
methods for the signal detection, etc.
– Prevention of adverse drug reactions: the prevention step aims at
facilitating the exchange of information through the well established
national and international networks. It manages specifically the
grave adverse drug reactions and the guidelines which help countries to
strengthen the pharmaceutical politics and decisions.
– etc.

The objective of this workshop is to gather people working on various
aspects of the pharmacovigilance. Experiments performed within academic,
instritutional or industrial contexts are welcome.


SUBMISSIONS:

The authors are invited to prepare 5 page submissions with the respect of
the MIE conference style:
- http://www.mie2012.it/documents/fullpaper.dot
- http://www.mie2012.it/documents/instruction.pdf

For any questions, please contact natalia.grabar at univ-lille3.fr


IMPORTANT DATES:

May 1, 2012: 1st call for submissions
June 15, 2012: Paper due date
July 10, 2012: Notifications to Authors
July 25, 2012: Camera-ready version
Aug 28, 2012: MIE conference and workshop


SCIENTIFIC COMMITTEE:

- Ismaïl Ahmed, Equipe Biostatistique, CESP, UMRS 1018 Inserm, Université
Paris Sud, France
- Andrew Bate, Visiting Professor, Department of Information Systems and
Computing, Computing and Mathematics, Brunel University, London, UK,
Adjunct Associate Professor of Medicine, Division of Clinical Pharmacology
NYU School of Medicine, New York, USA and faculty of the NYU Center for
Health Informatics and Bioinformatics, USA
- Kevin Cohen, University of Colorado School of Medicine and University of
Colorado at Boulder, USA
- Mélanie Courot, BC Cancer Agency, Vancouver, Canada
- Reinhard Fescharek, Behring Inc., Germany
- Thierry Hamon, LIM&BIO, Université Paris 13, France
- Mikaela Keller, CNRS LIFL UMR8022, Mostrare INRIA, Université Lille 1
and 3, France
- Halil Kilicoglu, National Library of Medicine, NIH, USA
- Niklas Noren, Uppsala Monitoring Centre, WHO Collaborating Centre for
International Drug Monitoring, Uppsala, Sweden
- Patrick Ruch, University of Applied Sciences, Geneva, Switzerland
- Ozlem Uzuner, University at Albany, SUNY, USA
- ...


ORGANIZERS:

Marie Dupuch, CNRS STL UMR 8163, U Lille 1 et 3, France
Frantz Thiessard, ISPED, U Bordeaux Segalen, France
Natalia Grabar, CNRS STL UMR 8163, U Lille 1 et 3, France
Jim Slattery, European Medicines Agency, London, UK



-- 
Natalia GRABAR
CR1 CNRS, UMR 8163, Université Lille 3, France
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listserv.linguistlist.org/pipermail/corpora/attachments/20120601/e924089f/attachment.htm>
-------------- next part --------------
_______________________________________________
UNSUBSCRIBE from this page: http://mailman.uib.no/options/corpora
Corpora mailing list
Corpora at uib.no
http://mailman.uib.no/listinfo/corpora